176 related articles for article (PubMed ID: 3549097)
1. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
Fleisch H
Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates--history and experimental basis.
Fleisch H
Bone; 1987; 8 Suppl 1():S23-8. PubMed ID: 3318890
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of the bisphosphonates.
Fleisch H
Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
[TBL] [Abstract][Full Text] [Related]
5. [Diphosphonates in the treatment of bone metastases].
Jung A; Fleisch H
Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism.
Fleisch H
Recent Results Cancer Res; 1989; 116():1-28. PubMed ID: 2669065
[TBL] [Abstract][Full Text] [Related]
7. Management of Paget's disease of bone.
Langston AL; Ralston SH
Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
[TBL] [Abstract][Full Text] [Related]
8. [Development of bisphosphonates].
Nakatsuka K
Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
[TBL] [Abstract][Full Text] [Related]
9. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
10. Diphosphonates inhibit bone resorption by macrophages in vitro.
Chambers TJ
J Pathol; 1980 Nov; 132(3):255-62. PubMed ID: 7431161
[TBL] [Abstract][Full Text] [Related]
11. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
Chapurlat R; Meunier PJ
Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in the treatment of disorders of mineral metabolism.
Singer FR; Minoofar PN
Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
[TBL] [Abstract][Full Text] [Related]
13. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
Pirih FQ; Zablotsky M; Cordell K; McCauley LK
J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonates in pharmacotherapy of bone diseases].
Iur'ieva EA; Matkovskaia TA; Elagina IA; Stoliarov IuIu
Eksp Klin Farmakol; 2000; 63(3):74-9. PubMed ID: 10934603
[TBL] [Abstract][Full Text] [Related]
15. Experimental basis for the clinical use of diphosphonates in Paget's disease of bone.
Fleisch H
Arthritis Rheum; 1980 Oct; 23(10):1162-71. PubMed ID: 6252908
[No Abstract] [Full Text] [Related]
16. [Diphosphonates. Current trends and therapeutic prospects].
Raviolo P; Galvagno G; Biarese V; Lovisetto P
Clin Ter; 1989 Apr; 129(1):31-41. PubMed ID: 2525450
[TBL] [Abstract][Full Text] [Related]
17. Current treatment approaches for Paget's Disease of Bone.
Brandi ML
Discov Med; 2010 Sep; 10(52):209-12. PubMed ID: 20875342
[TBL] [Abstract][Full Text] [Related]
18. Diphosphonates. Mode of action and clinical applications.
Fleisch H; Fast D; Rizzoli R; Trechsel U; Bonjour JP
Adv Exp Med Biol; 1977; 81():279-89. PubMed ID: 197817
[No Abstract] [Full Text] [Related]
19. [Histomorphometric study of nonpagetic bone in Paget patients. Results before and after diphosphonates].
Coindre JM; Edouard CM; Arlot ME; Meunier PJ
Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):103-9. PubMed ID: 7063793
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease of bone.
Haddad JG
Curr Ther Endocrinol Metab; 1994; 5():525-7. PubMed ID: 7704787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
